Johnson & Johnson: COVID-19 vaccine is 66% effective overall in global trial

Eren Sengezer FXStreet

Johnson & Johnson announced on Friday that its COVID-19 vaccine was 66% effective overall in the global trial, as reported by Reuters. The company further noted that the vaccine was 72% effective in the US portion of the trial.

Market reaction

This headline seems to be weighing heavily on market sentiment. As of writing, the S&P 500 Futures were down 1.2% on a daily basis. Meanwhile, Germany's DAX 30 was losing 1.35% and the UK's FTSE 100 was falling 1.9%.

Additional takeaways

"Vaccine is 57% effective in South Africa portion of trial."

"Vaccine is 85% effective overall in preventing severe disease."

"Single-dose covid vaccine was generally well tolerated."

"Looking to file in early February for US Emergency Use Authorization."

"Will have vaccine ready to ship immediately following authorization."

"Expecting to meet 2021 vaccine supply commitments."

Author

Eren Sengezer

FXStreet

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

AUD/USD remains depressed 0.7000, awaits FOMC Minutes

AUD/USD struggles to capitalize on its recent recovery move and trades with a negative bias below 0.7000 in Wednesday's Asian session. Amid geopolitical uncertainty, the US Dollar attracts some dip-buyers after a fresh leg up in US bond yields, keeping the pair under pressure despite hawkish RBA expectations. All eyes now remain on the FOMC Minutes.

USD/JPY holds firm near 158.50 ahead of Fed Minutes

USD/JPY hangs close to a one-and-a-half-week high near 158.50 in the Asian session on Wednesday, with bulls now awaiting a move beyond the 200-day SMA hurdle before positioning for further gains ahead of the FOMC Minutes. Meanwhile, a fresh leg up in US bond yields revives US Dollar demand amid geopolitical uncertainties, boosting the pair amid dovish BoJ commentary.

Gold weakens further; door open to $4,000?

Gold leaves behind Tuesday’s decent advance and recedes toward levels just above the key $4,000 mark per troy ounce on Wednesday. The precious metal’s sharp pullback comes in tandem with marked gains in the US Dollar and a marked bounce in US Treasury yields across the curve.

Crypto Today: Bitcoin, Ethereum and XRP fall liquidating $550M

Bitcoin’s correction follows a recent rejection due to supply around $87,200. Altcoins are generally in a correction trend, as Ethereum edges lower toward the next key support at $2,600 and Ripple extends its down leg near the $1.45 demand area.

Fed Minutes set to provide some insight into the timing of next rate hikes

The United States (US) Federal Reserve (Fed) will release the Minutes of September’s Federal Open Market Committee (FOMC) meeting on Wednesday. Investors are eager for some details that shed light on the extent and the timing of the central bank´s tightening cycle after approving the first interest rate hike in three years in September.

Eurozone inflation just hit 3.8%, its highest in three years. This chart shows why the ECB can’t simply hike its way out

The ECB would normally have a relatively straightforward answer to inflation running almost twice its target: raise interest rates. But these are not normal circumstances. This time, the bond market is already doing part of the tightening for it, leaving the ECB facing an increasingly difficult dilemma.